BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24932571)

  • 61. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
    Ma Z; Wang X; He J; Xia J; Li Y
    PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of PIWIL1 Isoforms and Their Expression in Bovine Testes, Oocytes, and Early Embryos.
    Russell SJ; Stalker L; Gilchrist G; Backx A; Molledo G; Foster RA; LaMarre J
    Biol Reprod; 2016 Apr; 94(4):75. PubMed ID: 26911426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Expression of Jagged1 mRNA in human epithelial ovarian carcinoma tissues and effect of RNA interference of Jagged1 on growth of xenograft in nude mice].
    Liu GY; Gao ZH; Li L; Song TT; Sheng XG
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):448-53. PubMed ID: 27356481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.
    Ren X; Wu X; Hillier SG; Fegan KS; Critchley HO; Mason JI; Sarvi S; Harlow CR
    J Steroid Biochem Mol Biol; 2015 Jun; 150():54-63. PubMed ID: 25817828
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.
    Xu L; Li H; Su L; Lu Q; Liu Z
    Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
    Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
    Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer.
    Huang K; Geng J; Wang J
    Cancer Sci; 2018 May; 109(5):1428-1446. PubMed ID: 29478268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
    Peng DX; Luo M; Qiu LW; He YL; Wang XF
    Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
    Wang Y; Wang H; Song T; Zou Y; Jiang J; Fang L; Li P
    Mol Med Rep; 2015 Aug; 12(2):2211-6. PubMed ID: 25824616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
    Dong L; Che H; Li M; Li X
    Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
    Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
    Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma.
    Lin Y; Xu T; Tian G; Cui M
    J Int Med Res; 2014 Apr; 42(2):300-6. PubMed ID: 24595148
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detection of PIWI and piRNAs in the mitochondria of mammalian cancer cells.
    Kwon C; Tak H; Rho M; Chang HR; Kim YH; Kim KT; Balch C; Lee EK; Nam S
    Biochem Biophys Res Commun; 2014 Mar; 446(1):218-23. PubMed ID: 24602614
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing.
    Zhao Q; Qian Q; Cao D; Yang J; Gui T; Shen K
    J Ovarian Res; 2018 Apr; 11(1):31. PubMed ID: 29685168
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
    Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
    J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
    [TBL] [Abstract][Full Text] [Related]  

  • 78. cDNA Cloning of Feline PIWIL1 and Evaluation of Expression in the Testis of the Domestic Cat.
    Stalker L; Backx AG; Tscherner AK; Russell SJ; Foster RA; LaMarre J
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298298
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of EZH2 and DNA methylation in hMLH1 silencing in epithelial ovarian cancer.
    Wang J; Yu L; Cai J; Jia J; Gao Y; Liang M; Wang Z
    Biochem Biophys Res Commun; 2013 Apr; 433(4):470-6. PubMed ID: 23523787
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of ascites-derived ovarian tumor cells from spontaneously occurring ovarian tumors of the chicken: evidence for E-cadherin upregulation.
    Tiwari A; Hadley JA; Hendricks GL; Elkin RG; Cooper T; Ramachandran R
    PLoS One; 2013; 8(2):e57582. PubMed ID: 23460878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.